Recent Finacing
Recent Raise
Ambys Medicines develops scalable cGMP manufacturing and allogeneic hepatocyte therapies (AMI-918 and follow-on programs) plus gene and protein-replacement approaches for acute, chronic, and decompensated liver disease.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Ambys Medicines.
